Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2005
08/03/2005EP1284737B1 Water soluble prodrugs of azole compounds
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP1237567B1 Method for administering a cytokine to the central nervous system and the lymphatic system
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1207861B1 Treatment of fungal infections utilizing a fungal growth medium
08/03/2005EP1196439B1 Compounds exhibiting an antibiotic activity
08/03/2005EP1175433B1 Androgen glycosides and androgenic activity thereof
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1123710B1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer
08/03/2005EP1012285B1 Beta-defensins
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/03/2005CN1650020A Means and methods for the production of adenovirus vectors
08/03/2005CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
08/03/2005CN1650012A Antigens encoded by alternative reading frame from pathogenic viruses
08/03/2005CN1650005A Antimicrobial polypeptide and utizliation thereof
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649894A A method for identification, isolation and production of antigens to a specific pathogen
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649883A Bicyclic 6-alkylidene-penems as lactamases inhibitors
08/03/2005CN1649882A Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649866A 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649618A Methods
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649606A Treatment of surfaces populated by bacteria
08/03/2005CN1649605A Use of topical compositions for the control of microbial diseases of the nail
08/03/2005CN1649603A Aqueous compositions containing metronidazole
08/03/2005CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649591A Tricyclic compounds useful as HIV reverse transcriptase inhibitors
08/03/2005CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1649508A Use of fermented wheat-germ in feeding and veterinary practice
08/03/2005CN1648249A Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression
08/03/2005CN1648128A Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine
08/03/2005CN1648126A Compound and its preparing method and use
08/03/2005CN1647824A Virus gene recombining technology and grafting therapeutic method
08/03/2005CN1647823A Sars冠状病毒全病毒疫苗 Sars coronavirus whole virus vaccine
08/03/2005CN1647813A Medicine for treating hepatitis and its preparing method
08/03/2005CN1647812A Chinese medicine composition and its preparing method
08/03/2005CN1647806A Leadless plaster medium for Chinese medicine and preparing method
08/03/2005CN1647801A Staphylococcus aureus metabolic product medicine oral preparation and its use
08/03/2005CN1647795A Fatty acyl acetaldehyde transfusion preparation and its preparing method
08/03/2005CN1647794A Fatty acyl acetaldehyde powder projection and its preparing method
08/03/2005CN1213145C Modified EB virus LMP1 coding sequence and its prepn and application
08/03/2005CN1213068C Improvments in or relating to immune responses to HIV
08/03/2005CN1213055C Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1212840C Slow-releasing kurarinol preparation and its preparing method
08/03/2005CA2479385A1 Use of propargylamine as neuroprotective agent
08/02/2005US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924362 Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
08/02/2005US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924287 Respiratory syncytial virus replication inhibitors
08/02/2005US6924283 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents
08/02/2005US6924282 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids
08/02/2005US6924279 An antibiotics for treating bacterial infections; bactericides
08/02/2005US6924270 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara
08/02/2005US6924118 Recombinant intracellular pathogen immunogenic compositions and methods for use
08/02/2005US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches
08/02/2005US6923988 Solid carrier includes a hydrophililc surfactant and a drug
08/02/2005US6923981 Fast dissolving orally consumable films
08/02/2005US6923970 Retrovirus-like particles made non-infectious by a plurality of mutations
08/02/2005US6923957 Inactivated virulence genes
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
08/02/2005CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects
07/2005
07/28/2005WO2006080954A1 Ketolide derivatives as antibacterial agents
07/28/2005WO2005068491A1 Antitumoral and antiviral peptides
07/28/2005WO2005068429A1 Derivatives of pyridine and quinoline
07/28/2005WO2005067955A1 Antimicrobial activity from medicinal mushrooms
07/28/2005WO2005067949A1 Antiviral preparation
07/28/2005WO2005067948A2 Biological medicine for treating various diseases caused by various virus, bacterial infection
07/28/2005WO2005067941A1 Topical aciclovir formulation
07/28/2005WO2005034838A3 Protease inhibitors
07/28/2005WO2005027936A3 Pharmaceutical compositions and therapeutical treatment with oligo-beta-(1, 3)-glucans
07/28/2005WO2004052891A8 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors
07/28/2005US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles
1 ... 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 ... 1798